Standardized Headache Therapy in the Pediatric Emergency Department Using Improvement Methodology.

Area of Science:

• Pediatric Emergency Medicine
• Neurology
• Clinical Quality Improvement

Background:

• Primary headache is a frequent reason for pediatric emergency department (PED) visits.
• Lack of evidence-based guidelines leads to inconsistent and potentially ineffective treatments.
• This study aimed to standardize primary headache management in the PED.

Purpose of the Study:

• Promote evidence-based therapies for primary headaches.
• Reduce the use of nonstandard abortive treatments.
• Integrate dihydroergotamine (DHE) as a treatment option for refractory cases.

Main Methods:

• A multidisciplinary team developed a clinical care algorithm and updated electronic medical record order sets.
• Key outcome measures included rates of evidence-based and nonstandard therapies, DHE administration, and length of stay.
• Process and balancing measures assessed order set utilization, timely medication administration, hospital admissions, and return visits.

Main Results:

• Evidence-based therapy use increased from 69% to 73%; nonstandard therapy use decreased from 2.5% to 0.6%.
• Dihydroergotamine (DHE) use for first-line therapy failures rose from 0% to 37.2%.
• Improvements were sustained for 14 months with no negative impact on length of stay, admissions, or return visits.

Conclusions:

• Standardization successfully enhanced evidence-based primary headache treatment in the PED.
• Nonstandard therapies were significantly reduced, and DHE use improved for resistant migraines.
• The quality improvement initiative achieved positive outcomes without compromising patient safety or increasing healthcare utilization.